ALTI-BROMAZEPAM 3MG TABLETS
ALTI-BROMAZEPAM 3MG TABLETS
Discontinued
DIN Number
02167816
Drug Class
Human
Market Date
Dec 31, 1995
Company
HC
altimed pharma inc.
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02167816
AIG Number0114488003
Classification & Schedule
C
Drug Class
Human
S
Schedule
Targeted (CDSA IV)
A
ATC Code
N05BA08 BROMAZEPAM
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification28:24.08
Health Canada Classification
ACTIVE INGREDIENTS (1)
BROMAZEPAMActive
Strength: 3 MG
Monograph: BROMAZEPAM